Cyntegrity – Risk-based Monitoring Solutions 2018-01-16T09:26:51+00:00

Be Efficient By Nature

Cyntegrity (origin: clinical + integrity), an innovative company inspired by efficiency, provides a specialized software tool for the risk-based monitoring (RBM).

Our mission is to help a pharmaceutical company to stay GCP compliant, improve patient safety, make a clinical study more predictable, and optimise monitoring resources. In other words: prevent surprises.

We offer trial management tools that are more predictive than retrospective. They integrate the knowledge from previous trials with contextual, real-world data.

Risked-based Monitoring Tool

Our RBM.Cloud builds up a “nervous system” of a clinical trial. It guarantees early risk identification by providing a centralized location where risk data are saved, managed, monitored, and reported.

icon-risk-assessment

@RACT

Risk Assessment and Categorization Tool

@RACT

@RACT® – the first free cloud version of Risk Assessment and Categorization Tool, originally developed by TransCelerate Group and improved further by Cyntegrity in cooperation with PPH plus. Register today for free!

learn more
icon-risk-based-monitoring

What is RBM

Risk-based Monitoring

What is RBM

Risk-based Monitoring (RBM) is becoming an essential concept in pharmaceutical clinical research today.
Which has potential to reduce clinical costs and improve data quality, and time-to-market of a medicine.

learn more
icon-early-bird - RBM.cloud

RBM.cloud

Detect, Manage, Mitigate

RBM.cloud

Detect, Manage, Mitigate
Together with the application EarlyBird® Cyntegrity conducts total risk management of a clinical trial. It analyses data driven KRIs, builds reports and Risk-based Monitoring dashboard.

learn more

 

 Recent Posts

Adaptive Monitoring: Anticipating The Human Factor

March 21, 2018|Comments Off on Adaptive Monitoring: Anticipating The Human Factor

An effective way to control risks during a clinical trial is to anticipate events induced by human factor before the study even begins. Dr Johann Proeve's third chapter on Adaptive Monitoring talks about how human factor is complementary to numeric data.

The Three Biggest Challenges in RBM Related to Key Risk Indicators

March 14, 2018|Comments Off on The Three Biggest Challenges in RBM Related to Key Risk Indicators

Our online KRI (Key Risk Indicator) survey indicated that finding the right calculation method seems the most challenging aspect of the application of KRIs. In addition our survey showed that the vast majority (> 95%) makes use of KRIs. Do these results surprise you?

Adaptive Monitoring: Beyond Data Trends and Timely Performance

March 7, 2018|Comments Off on Adaptive Monitoring: Beyond Data Trends and Timely Performance

Adaptive Monitoring is not a “status quo”, it is a dynamic response to clinical research that drives monitoring scope and activities to the evolving areas of greatest need which have the most potential to positively impact. Each clinical study requires its own tailored monitoring approach ensuring risks are minimized.

Latest News

Blockchain in Clinical Trials – The Ultimate Data Notary

March 14, 2018|Comments Off on Blockchain in Clinical Trials – The Ultimate Data Notary

Blockchain technology is the biggest achievement in cryptography of the past decade. Source Data Verification (SDV), which consumes about 20–30% of the clinical trial budget nowadays, will become redundant when blockchain technology disrupts the pharma industry.

A Simple 5-step Plan to Improve Quality and Efficiency in Clinical Trials

March 2, 2018|Comments Off on A Simple 5-step Plan to Improve Quality and Efficiency in Clinical Trials

Last February 28th, the FDA finalized the E6 (R2) version of the addendum to the International Council for Harmonisation's (ICH) good clinical practice (GCP) guideline. What to do now? Don’t panic, we’ve put together a simple 5-step plan to help you initiate the most urgent process adaptations.

Press Release: Cyntegrity Rolls out SaaS Application to Help Pharma Organisations Bring Regulatory Guidance into Practice

February 27, 2018|Comments Off on Press Release: Cyntegrity Rolls out SaaS Application to Help Pharma Organisations Bring Regulatory Guidance into Practice

Frankfurt – Cyntegrity, a German provider of proprietary Risk-based Monitoring (RBM) cloud services for [...]

Cyntegrity’s RBM Platform “EarlyBird” offers a variety of useful components to support Risk Based Monitoring. I’m looking forward to the first Implementation in one of our next studies.
Steffen Koenig, President at DGGF e.V. (German Society for Good Research Practice), General Manager at IST GmbH
Cyntegrity’s @RACT is not just a cloud-based version of RACT. It is a comprehensive system that follows a solid risk management process. @RACT reinforces that process with in-depth analysis tools to support real-time decision making at both the study and enterprise levels.
Keith Morgenstern, Director Metrics Programs Metrics Champion Consortium
Great that Cyntegrity offers a tool that operationlizes the TransCelerate RACT tool; even better that this enables through a common platform the sharing of risk assessments what will be key to quality risk management as we should learn from IATA!
Beat E. Widler PhD ETH-Z, Managing Partner Widler & Schiemann Ltd.
I think you developed already a great tool, at least from the look and feel point of view. I have no idea how cumbersome the implementation is, how much programming is required etc. I can also imagine that coming to an agreement on what is a risk and the definition for it probably takes most of the time.
Dr. Johann Proeve, Global Development and Strategy Advisor in Global Data Sciences and Analytics at Bayer HealthCare

Upcoming Events

  1. SCDM 2018 ANNUAL CONFERENCE – Seattle

    September 23 - September 26
  2. PCT Europe 2018

    November 28 - November 29

Register Today!

Get Free Test Access